National Health Investors, Inc. (NHI)
NYSE: NHI · Real-Time Price · USD
67.80
-1.43 (-2.07%)
Sep 18, 2026, 4:00 PM EDT - Market closed
← View all transcripts

Earnings Call: Q4 2019

Feb 19, 2020

Operator

Greetings, welcome to the 2019 National Health Investors Conference Call. During the presentation, all participants will be in a listen-only mode. Afterwards, we will conduct a question and answer session. At that time, if you have a question, please press the one followed by the four on your telephone. If at any time during the conference you need to reach an operator, please press star zero. As a reminder, this conference is being recorded Wednesday, February 19th, 2020. I would now like to turn our conference over to Dana Hambly. Please go ahead.

Dana Hambly
Director of Investor Relations, National Health Investors

Thank you, and welcome everyone to the National Health Investors Conference Call to review the company's results for the fourth quarter of 2019. On the call with me today are Eric Mendelsohn, President and CEO, Kevin Pascoe, Chief Investment Officer, and John Spaid, Executive Vice President and Chief Financial Officer. The results, as well as the notice of the accessibility of this conference call on a listen-only basis over the internet, were released this morning before the market opened in a press release that's been covered by the financial media. As we start, let me remind you that any statements in this conference call which are not historical fact are forward-looking statements. NHI cautions investors that any forward-looking statements may involve risk or uncertainties and are not guarantees of future performance. All forward-looking statements represent NHI's judgment as of the date of this conference call.

Investors are urged to carefully review various disclosures made by NHI and its periodic reports filed with the Securities and Exchange Commission, including the risk factors and other information disclosed in NHI's Form 10-K, for the year ended December 31st, 2019. Copies of these filings are available on the SEC's website at www.sec.gov or on NHI's website at www.nhireit.com. In addition, certain terms used in this call are non-GAAP financial measures, reconciliations of which are provided in NHI's earnings release and related tables and schedules, which have been filed on Form 8-K, with the SEC. Listeners are encouraged to review those reconciliations provided in the earnings release together with all other information provided in that release. I'll now turn the call over to Eric Mendelsohn.

Eric Mendelsohn
President and CEO, National Health Investors

Thank you, Dana. Hello, everyone, and thanks for joining us today. We are pleased to report our fourth quarter and full year results for 2019, which were at the top end of our guidance range, despite the many headwinds that we faced last year. We started 2019 in a much more defensive posture than is usual for NHI, and we experienced good momentum throughout the year. We are in much better shape as we enter 2020. We are not out of the woods by any means, as the senior housing industry continues to be challenged by new deliveries and labor issues, which we do not expect to improve for at least the next several quarters. We are generally encouraged by slowing inventory growth and very strong net absorption, which in 2019 showed the highest level of demand in the 13 years since NIC has been collecting this data.

Furthermore, our skilled nursing portfolio continues to show very strong coverage, and we expect that the new PDPM reimbursement system will moderately improve on that coverage. We have remained optimistic despite some of the headwinds, and announced $329 million in acquisitions in 2019, primarily with existing partners. We also added three new partners with whom we are excited to grow with for many years to come. In 2020, we have already announced $150 million, including $135 million for Timber Ridge, which is a Class A CCRC just outside of Seattle, and we are thrilled to partner with LCS on this deal. Kevin will share more details later. With the Timber Ridge acquisition, we are dipping our toes back into RIDEA with a 25% interest in OpCo.

Unlike other RIDEA structures more common with healthcare REITs, we've done so with an embedded triple-net lease that mitigates volatility of the underlying operation to NHI shareholders. We are always open to creative financing solutions with premier operators like LCS, and investors should expect that our focus will continue to be on the triple-net strategy. We recently announced a 5% increase in our dividend, which marks the 11th straight year we have increased the quarterly dividend by 5% or more while maintaining a coverage ratio below 80% of normalized FFO for the last seven years. This makes us a dividend achiever if you keep track of such things. We are not satisfied with the limited per-share growth that we experienced in 2019, and our G&A reflects that in the form of reduced executive compensation this year. This demonstrates accountability to shareholders.

We worked hard to anticipate areas that need attention and proactively addressed issues in a transparent manner. As we talked about on our third quarter call, we expect that we will return to mid-single-digit growth this year. John will discuss the guidance in more detail. I will add that we have good visibility on our outlook and that our desire is always to underpromise and overdeliver. With that, I'll turn the call over to John.

John Spaid
EVP and CFO, National Health Investors

Thank you, Eric, and good morning, everyone.

I'm pleased to report a solid quarter in year-end of 2019, as well as 2020 guidance, more representative of historic NHI growth. Beginning with our three FFO performance metrics on a diluted common share basis for the fourth quarter ending December 31st, 2019, NAREIT FFO increased 6.9% to $1.39, normalized FFO increased 4.4% to $1.41, and adjusted FFO increased 2.4% to $1.30. On a full year basis, NAREIT FFO per diluted common share increased 2.4% to $5.49, normalized FFO increased 0.7% to $5.50, and adjusted FFO increased 1.2% to $5.10, which as Eric previously mentioned, was at the top end of our guidance range. Reconciliations for our pro forma performance metrics can be found in our earnings release and 10-K, filed this morning at sec.gov. I want to now talk about our cash NOI. Cash NOI is a metric we use to measure our performance.

We define cash NOI as GAAP revenue, excluding straight-line rent, excluding escrow funds received from tenants, and excluding lease incentive and commitment fee amortizations. For the year ending December 31st, 2019, cash NOI increased 7% to $290.5 million compared to $271.5 million in the prior year. Our increase in 2019 cash NOI was reflective of our organic NOI growth from lease escalators, our partial year contributions from newly announced 2019 investments, our continued fulfillment in 2019 of the prior year's announced investments, offsets by impacts due to the Holiday master lease restructuring, and finding new homes for the nine transition properties. A reconciliation of cash NOI can be found on page 17 of our Q4 2019 SEC filed supplemental. G&A expense for the 2019 fourth quarter increased 28% over the prior year fourth quarter. For the entire year increased 6.8% over 2018 to $13.4 million.

Included in the fourth quarter and full year 2019 G&A expense was approximately $716,000 in severance. Excluding the severance expense, G&A increased 2.7% in the fourth quarter over the prior year's fourth quarter and 1.1% for the full year compared to 2018. As Eric mentioned in his opening remarks, the flat year-over-year G&A expense growth is reflective of our muted executive compensation for NHI's 2019 performance. Turning to the balance sheet, we ended the year with $1.44 billion in total debt, of which a little over 90% was unsecured. At December 31st, we had $250 million in capacity on our $550 million revolver.

During December, NHI entered into privately negotiated agreements with certain holders of our 3.25% convertible senior notes, under which we issued 626,397 shares of NHI common stock, plus cash consideration and payment of fees totaling $22.1 million to redeem $60 million in aggregate principal amount of our outstanding convertible notes. As a result of the redemption at year-end, NHI's aggregate balance of convertible notes is now $60 million, which will mature in April of 2021. Our debt capital metrics for the quarter ending December 31st were net debt to annualized adjusted EBITDA at 4.7 times, weighted average debt maturity at four years, and our fixed charge coverage ratio at 5.7 times. For the quarter ended December 31st, our weighted average cost of debt was 3.54%. We've mentioned in prior calls that we expect 2020 to be a transformative year for NHI's balance sheet, and the interest rate is currently favorable.

Our announced public credit ratings allow us to consider the public debt markets. Our current shelf registration is expiring, and we'll be filing the new shelf registration in the coming weeks. Stay tuned on more to come in the forthcoming quarters as we look to term off our revolver balance and make room for future growth. This morning, we issued our 2020 guidance. We expect NFFO to be in the range of $5.67-$5.71 per diluted share, or an increase of 3.5% at the midpoint. We also expect AFFO to be in the range of $5.31-$5.35, or an increase of 4.5% at the midpoint. Our guidance continues to reflect management's intent to underpromise and overdeliver.

Our guidance issued today includes effects from the recently announced Brookdale purchase option, expected contributions from the recently announced Timber Ridge joint venture, continued fulfillment of our commitments as detailed in our 10-K, and line of sight on unannounced investments under LOIs totaling approximately $50 million. Our guidance also reflects our views on our transition properties. While we don't expect the cash NOI in the nine transition properties to return to 2018 levels this year, we do expect them to get to between 40% and 45% of the way back to 2018 levels. We do believe, though, after straight-line rent, the GAAP revenues for the transition properties will get to between 60% and 65% of the way back to the 2018 levels.

Our guidance this year includes assumptions for terming off our revolver debt and further assumes that we will continue to make additional investments on a leverage-neutral basis. In addition to our per share guidance, we wanted to also give guidance on several items that many of you use to evaluate our FAD performance. In addition to non-cash stock compensation, which you'll see referenced in our reconciliation table as part of this morning's earnings release, moving forward, we wanted to also provide you with pro forma routine capital expenditure and non-refundable entrance fee cash flows attributable to our 25% share in the Timber Ridge OpCo. Together with our earnings release this morning, we also announced our first-quarter dividend. We increased our quarterly dividend 5% or $0.0525 to $1.1025 per common share.

The first quarter dividend is payable May to shareholders of record March 31st, 2020. As Eric mentioned in his opening remarks, we started 2019 off on defense, but ended the year back on offense, and 2020 is shaping up to be a good year for NHI. With that, I'll now turn the call over to Kevin Pascoe to discuss our portfolio. Kevin?

Kevin Pascoe
Chief Investment Officer, National Health Investors

Thank you, John. Looking at the overall portfolio at the end of the third quarter, the EBITDARM coverage ratio was 1.66 times for the total portfolio, compared to 1.65 times in the year earlier period and 1.69 times in the prior quarter. Senior housing coverage declined year-over-year as expected to 1.14 times, compared to 1.23 times last year and 1.15 times in the prior quarter. Our skilled portfolio at 2.73 times improved from 2.55 times last year, but declined from 2.8 times in the June quarter. The sequential decline is attributable to NHC as the non-NHC SNF coverage improved to 1.92 times from 1.87 times in the June quarter. We are still very comfortable with the NHC coverage, which was 3.69 times in the third quarter.

Our ample SNF coverage is a testament to the hard work of our best-in-class operators, and while the senior housing industry continues to be challenged by supply and labor issues, we have not seen a meaningful shift in operating trends and feel our operating partners are doing a good job of competing in their respective markets. According to recent NIC data, properties with an average age of 10-17 years have the highest occupancy, followed by properties with an average age of 25-plus years. Interestingly, the lowest occupancy was reported for properties with an average age of 2-10 years. This tells us that performance is operator-driven , consistent with our philosophy, and that the newest buildings will not always garner the most market share.

Turning to our operators by revenue, Bickford Senior Living represents 18% of our cash revenue and had an EBITDARM coverage ratio of 1.07 times for the trailing 12 months ended September 30th. On a same-store basis, the Bickford EBITDARM coverage is 1.12 times. Including a development property, which will roll into the coverage calculation in the fourth quarter, the Bickford total and same-store coverage was 1.09 times and 1.14 times, respectively. Due to the lagging nature of EBITDARM coverage and in an effort to provide more transparency, we have continued to disclose Bickford's occupancy. Bickford's occupancy started to turn positive in the second quarter, which continued through the third quarter. We are pleased to report that Bickford's fourth quarter occupancy remained steady on a sequential basis and showed significant improvement year-over-year.

Bickford's total and same-store leased portfolio occupancy improved by 160 basis points and 230 basis points, respectively in the fourth quarter of 2019 compared to the same quarter in 2018. Importantly, Bickford has maintained price discipline while showing this improved occupancy. Lastly, NHI exercised its purchase option on the Bickford Shelby property for $15.1 million at an initial yield of 8% during the first quarter of 2020. This transaction is similar to the Bickford Gurnee deal in that it replaces a $14 million construction loan we had in place previously. We have similar agreements on two other Bickford properties, which we believe will help stabilize and improve our coverage with this operator. Developing new assets with Bickford will help us continue to evaluate additional asset sales while maintaining our relationship with Bickford and upgrading the portfolio.

Moving to Senior Living Communities, our relationship with SLC represents 16% of our annualized cash revenue. Including net entry fee income, their EBITDARM coverage ratio was 1.1 times on a trailing 12-month basis. This compares to 1.28 times in the year-earlier period and 1.1 times for the June quarter. As discussed on prior calls, we are watching entry fee sales closely and leading sales indicators have started to turn positive, where SLC has purchased additional unit inventory. The benefit of entry fee sales will take some time to roll through the coverage calculation as the quarters with those inventory repurchases roll out of the calculation. Our next largest partnership is with NHC, which accounts for 14% of our annualized cash revenue. As previously mentioned, NHC had a corporate fixed charge coverage of 3.69 times in the September quarter.

Lastly, Holiday Retirement, which represents 12% of our cash revenue, had an EBITDARM coverage ratio of 1.21x , which is a slight improvement on both a year-over-year and sequential basis. Recall that we restructured the master lease with Holiday at the beginning of 2019, which required some difficult decisions at the time. The goal was always to put Holiday in a better position operationally and financially while acting in the best interest of our shareholders. While the story continues to play out, we are encouraged by the outcome just over a year later. Moving on to new investments. In the fourth quarter, we continued to expand our relationship with 41 Management with the acquisition of a 48-unit assisted living and memory care community in the St. Paul, Minnesota area for $9.34 million at an initial cash yield of 7.23%.

We also extended a second mortgage loan of $3.87 million at a rate of 13% on an assisted living community in Bellevue, Wisconsin. This is a one-year loan with extension options, and NHI has a purchase option on the community upon stabilization. We also exercised our purchase option and formed a joint venture with LCS to own and operate the 401-unit Timber Ridge CCRC for $135 million, effective January 31st. As Eric mentioned earlier, this deal includes a RIDEA structure whereby NHI holds an 80% interest in the PropCo and a 25% interest in the OpCo. PropCo is leasing the community to OpCo under a seven-year triple net lease at an initial yield of 6.75%. NHI is also bringing financing of $81 million to PropCo, or approximately 60% of the purchase price.

This is a Class A property in a high-barrier-to-entry and affluent market outside of Seattle with one of the premier CCRC operators in the country. Regarding the acquisition environment and pipeline, we announced $329 million in acquisitions during 2019, and we are off to a good start in 2020 with announced deals already totaling $150 million. We look forward to our new building opening in Milwaukee with Ignite Medical Resorts. Our $25 million investment has a yield of 9.5%, and we expect rent to commence when it opens in the second quarter. Valuations are still very competitive, but through a relationship-driven approach, we continue to see additional opportunity as we survey the market and are committed to adding high-quality operators and communities to the portfolio at yields comparable to what we have done in the last few years.

With that, I'll hand the call back over to Eric.

Eric Mendelsohn
President and CEO, National Health Investors

Thank you, Kevin. The challenges in this industry cannot simply be lumped into general categories like AL versus IL or primary versus secondary. NHI is committed to succeeding in all of the markets and products in which we invest. We are constantly reviewing our portfolio to identify opportunities that we can proactively address. We do this through a number of methods, and our preference is to always do it in unison with our operators and through a financial structure which leads to stability in our cash flow. As I mentioned earlier, we have good visibility in our outlook this year, and we look forward to updating you on our progress throughout the year. With that, operator, we'll now open the line for questions.

Operator

Thank you. If you would like to register a question, please press the one followed by the four on your telephone. You will hear a three-tone prompt to acknowledge your request. If your question has been answered and you would like to withdraw your registration, please press the one followed by the three. One moment for the first question. Our first question comes the line of Chad Vanacore with Stifel. Please proceed with your question.

Seth Canetto
Analyst, Stifel

Hey, good morning. This is Seth Canetto on for Chad.

John Spaid
EVP and CFO, National Health Investors

Hey, Seth.

Seth Canetto
Analyst, Stifel

Hey. John mentioned in his opening remarks about the strong cash NOI 7% in 2019. How should we be thinking about that in 2020? Do you guys have any guidance on that metric?

John Spaid
EVP and CFO, National Health Investors

Let's see. This is John. How should you be thinking about that? Obviously, it's going to go up. That's the easy answer. No, we don't have guidance on it. I think that the best way to explain it is, we have to grow our cash NOI in the 7% or greater range, which then, after we issue additional shares, is diluted back to the growth metrics that we need to get to our 5% target. Our 5% target on AFFO is roughly $0.26 over 2019. There's a lot of ins and outs that goes through all of our forecasts. We've had some outs this year, which includes some of the purchase options. That's why it gets a little bit tricky.

At the end of the day, we're trying to grow the company, and we're trying to grow the company through cash NOI, which eventually funnels down to how we're able to cover our dividend and also pay for all of our other capital. Yeah, it's a little bit tricky.

Seth Canetto
Analyst, Stifel

All right. Thanks. That's helpful. Then just looking at that Timber Ridge acquisition you guys did with that RIDEA structure, is that how we should think about you guys dipping your toe into the RIDEA structure going forward? Do you think there will be more deals structured like that?

Eric Mendelsohn
President and CEO, National Health Investors

Hey Seth, this is Eric. I think so. That's a structure that we have spent a lot of time and energy vetting with our legal advisors and tax advisors to make sure it works, and make sure that it's appealing from the joint venture partner perspective as well. Obviously, now that it's in place, we'll have some time to experience it as a joint venture partner and see how it works. We think it's a winning combination of exposing us to RIDEA in a limited sense, so that the operating performance, which is generally lumpy, will not interfere with our guidance and giving us some upside at the same time.

Seth Canetto
Analyst, Stifel

Eric, you mentioned that when we think about senior housing, we're not out of the woods yet. There's still new deliveries and labor issues affecting the industry. We really don't see a lot of improvement in 2020. How should we think about the show total portfolio coverage? I think it deteriorated from 123 last year to 114. I understand those are trailing numbers. How should we just think about that coverage metric moving forward?

Eric Mendelsohn
President and CEO, National Health Investors

Sure. Keep in mind, our reporting on coverage is, there's a two-quarter lag, one-quarter lag, so we're always looking in the rearview mirror. I think we've been very transparent about what's going on with Bickford, and we're starting to see the benefits of all of the work that we're doing with them. Just to reiterate, we're publishing current occupancy in our 10-K. We've adjusted their rent. We've sold, or are about to sell, underperforming buildings. We transitioned an underperforming building in Minnesota to another operator. While they're still supporting that rent this year, that will lessen next year. They have new developments that are coming on board that are improving their immediate coverage, which does not show up in same-store for two years. That's one way to think about the coverage.

The other is Senior Living Communities, and they have invested heavily in new product that was available for sale in their buy-in community, and that weighs on their coverage. Generally, we're optimistic and what we're seeing is an improving trend.

Seth Canetto
Analyst, Stifel

All right, great. That's it for me. Thanks for taking my questions.

Eric Mendelsohn
President and CEO, National Health Investors

Sure.

Operator

Our next question comes from line of Daniel Bernstein with Capital One. Please proceed with your question.

Daniel Bernstein
Analyst, Capital One

Hi, good afternoon.

Eric Mendelsohn
President and CEO, National Health Investors

Hey, Daniel

Daniel Bernstein
Analyst, Capital One

Hey. Just wanted to make sure, are you responsible for CapEx in the JV structure with LCS?

Eric Mendelsohn
President and CEO, National Health Investors

Because we're part owners in the OpCo, and because you're trying to understand the cash flows that we might recognize from the OpCo, we're giving you a little bit of guidance on what might help you sort of get to a performance metric on the OpCo as we move forward. When we, at the end of the day, make a decision about distributions out of the OpCo, you'll see the earnings loss on our profit and loss statement. You won't see some of the other sort of items that we'll have to sort of take care of before we make distributions. We're trying to give you some help on that. We're also trying to give you some help on how we're going to report ourselves moving forward.

John Spaid
EVP and CFO, National Health Investors

We haven't made final decisions on all that, but I think you're going to see components of all of these numbers in our first quarter results. Finally, one of the things I want to make sure I point out to you is that we might actually be able to distribute to ourselves more than our performance metrics indicate, because one of the things we're not really talking about is the refundable entrance fee portion of the cash flow streams that the OpCo will also see. That's more of a liquidity measure, so we try to stay away from those sort of measures. You'll hear Kevin talk more about that as we progress forward on the Timber Ridge joint venture.

Daniel Bernstein
Analyst, Capital One

Okay. On skilled nursing, it seems like you have some positive comments on PDPM, and we've seen some positive comments across the space from other REITs and operators as they report. When you think about your pipeline going forward, most of what you've done has been seniors housing. Do you think your pipeline might shift a little bit more balanced between skilled and seniors, or are you really more focused on seniors at this point?

Kevin Pascoe
Chief Investment Officer, National Health Investors

Hey Daniel, it's Kevin. I think our focus has never gone away from skilled nursing. It's really just been letting the market come back to where we want to transact on that in terms of just coverage and yield. Felt like we've seen that happen. We've been an active participant, so to speak, in terms of reviewing deals and trying to do some more investment there. I don't know that it changes the way we move forward. Again, I think we are still actively looking at skilled nursing. I don't think yet we're saying we're going to do more just because of that. I do think you'll see us make investments in the skilled space. We're just going to remain selective on what we go after.

Daniel Bernstein
Analyst, Capital One

Okay. What would be the holdup? Would it be competition around cap rates, lack of operator quality? What would get you more excited about skilled nursing versus where you are today or where you are last year?

Kevin Pascoe
Chief Investment Officer, National Health Investors

Sure. Operator quality always is going to be first and foremost. I think vintage is definitely something that weighs heavily on an investment decision, how old the buildings are. That said, if you've got a good operator and a good plan to invest some capital, we would definitely evaluate that. The things that have held us up before were really more where the market was pricing lease coverage on those types of assets, and it wasn't interesting at those levels. Again, I feel like we're starting to see more deal flow at levels where we would be interested. Stay tuned there, but it's definitely on our radar.

Daniel Bernstein
Analyst, Capital One

One last question, if I could. When it comes to supply growth within, say, Bickford and SLC Holiday markets, it seems if you look at the NIC MAP data, starts are coming down, supply growth is slowing. Within those markets that you're in, are you seeing that same type of trend? Maybe you don't see all that benefit this year, but over the next couple of years, if supply growth is going to slow down, you'd probably get some improvement in lease coverage. What is the supply outlook within the markets that you're invested in?

Kevin Pascoe
Chief Investment Officer, National Health Investors

It really depends on the market. Within Bickford, those general markets, we've seen some new supply, but really supply by itself hasn't hampered them all that much. I think you mentioned SLC. There's been a couple markets there, where there has been new delivery that has impacted them. It varies market to market very widely. We are, as you mentioned, see those deliveries happening, the absorption happening. It's going to take some time to get there, to soak up the inventory where there was new inventory, but it's not been rampant across the Bickford markets. There's been, as I mentioned, a select few there and then some in some of the SLC markets. We're watching those, but we feel like they're able to compete well.

The buildings look good, they maintain them, they're able to show well and still get sales, get people to move in, want to be a part of those communities.

Daniel Bernstein
Analyst, Capital One

Okay. I'll hop off. Thank you.

Kevin Pascoe
Chief Investment Officer, National Health Investors

Thanks, Daniel.

Operator

As a reminder to register for a question, please press one followed by the four on your telephone. Our next question comes line of John Kim with BMO Capital. Please proceed with your question.

John Kim
Analyst, BMO Capital Markets

Thank you. I was wondering if you could provide some insight on what you're seeing as far as CCRCs and the average, as well as the range of the non-refundable portion of the entrance fees, either in your existing portfolio or what you're underwriting at Timber Ridge.

Kevin Pascoe
Chief Investment Officer, National Health Investors

He's asking about non-refundable. Yeah. Again, this is one that changes or varies widely based on the community. In the instance of Timber Ridge, the entry fee component is much larger because it is of the asset quality and what they are able to charge for those entrance fees. It is a bigger proportion of entry fee income or entry fee receipts that they would be than, say, we are with Senior Living Communities, at least in some areas in the South where the entry fees would be lower. In terms of percentage, is that your question, the percentage of entry fee that is not refundable?

John Kim
Analyst, BMO Capital Markets

Yeah. Residents have different options, right? On what they could choose for the non-refundable part.

Kevin Pascoe
Chief Investment Officer, National Health Investors

If we're talking about Timber Ridge, there's really only one contract. It's an 80% return on capital contract. 20% plus the increase in value of that unit over the turnover time is what would be the non-refundable portion.

John Kim
Analyst, BMO Capital Markets

Is that pretty typical with your existing CCRC portfolio?

Kevin Pascoe
Chief Investment Officer, National Health Investors

No, it actually varies quite a bit. SLC has 90% return of capital or 90, 60, and 0. There's several different selections there. In a couple of our Connecticut communities, there's even more different options than that. I would say, and then within SLC, it's probably split almost 50/50 between the 60s and the 90s, in terms of the plan that the resident would choose. On average, I would say you're going to be 75%. A little bit different number, but just different contract types that are available. There's nuance between the return on capital components.

The type of building that it is. Timber Ridge is a Type A community. SLC is a Type C community or market rate. Some of those things will drive what they can charge, what the service fees are for each line of service that they're getting. There's a lot of components that go into entry fee, how it gets calculated, and ultimately what their return will be.

John Kim
Analyst, BMO Capital Markets

Can you remind us how are you accounting for this as far as the normalized FFO impact? Is it on a cash basis?

John Spaid
EVP and CFO, National Health Investors

So-

John Kim
Analyst, BMO Capital Markets

Are you amortizing the non-refundable portion?

John Spaid
EVP and CFO, National Health Investors

Depending on what line you're talking about, the net income line will have a recognition of the non-refundable piece that, and you're talking about with respect to Timber Ridge only, that is a function of the average resident's expected stay in the community. From there, we will, at the AFFO line, adjust out the non-cash amortization of the non-refundable entrance fees. We intend to give you a picture of what the actual cash flows will look like below the AFFO line for FAD purposes. I'll let you choose to use that information as you deem appropriate, and you'll see some irregularity in that cash flow as we move forward. What you won't see is the cash flows from the refundable entrance fees.

John Kim
Analyst, BMO Capital Markets

The adjustment is made to AFFO, but it will remain in the normalized FFO, is that correct?

John Spaid
EVP and CFO, National Health Investors

Yeah. Normalized FFO sort of contains all of those sort of revenue items like straight line rent. In this case, it'll contain the amortization of the non-refundable entrance fees at the NFFO line, but we'll back it out to get a little closer to the cash flow at the AFFO line and then give you the actual cash. This is just on the non-refundable entrance fee component.

John Kim
Analyst, BMO Capital Markets

Right. Okay.

John Spaid
EVP and CFO, National Health Investors

Okay.

John Kim
Analyst, BMO Capital Markets

Eric, you mentioned, in your prepared remarks that you remain committed to the triple net lease structure. It seems like a structure that's increasingly not working for a lot of operators, just given the CapEx and the rising rent. I'm wondering, is there anything you're doing as far as altering your leases to be more operator-friendly ? I know you're doing this joint venture with LCS and the OpCo, but is there anything else that you're doing on the triple net leases to resonate with operators?

Eric Mendelsohn
President and CEO, National Health Investors

Yes. We have done things like made our escalators CPI-based, so they don't get too far ahead of resident rent increases. We have done things like paid for renovations of buildings and added them to the lease basis. Even though we are contributing to CapEx, those dollars out are getting us an investment return. Generally, that's a formula that works. Finally, John, I think you've noticed we are very careful about our investments and the underwriting that we do, and we are constantly making sure that there is coverage that allows the tenant to, A, make money and make a profit on their efforts, and B, have enough left over for CapEx in the buildings. When that coverage is not there, we pay close attention to that. I would point to Bickford as an example of that.

John Kim
Analyst, BMO Capital Markets

Okay. Thank you.

Operator

Our next question comes from the line of Omotayo Okusanya with Mizuho. Please proceed with your question.

Omotayo Okusanya
Analyst, Mizuho

Hi. Yes, good afternoon, everyone.

Eric Mendelsohn
President and CEO, National Health Investors

Hey.

Omotayo Okusanya
Analyst, Mizuho

For the guidance number, I just had two clarifying questions. First of all, in regards to just investment/acquisition activity that's built into guidance, just wanted to confirm that is the loan commitments you still have out there, which you kind of lay out in the 10-K, the $150 million that you've done year to date. You also mentioned about $50 million also built in for deals that are in line of sight. Is that correct?

John Spaid
EVP and CFO, National Health Investors

That's correct. Don't forget, though, of the $150 million that are sort of subsequent event items, you might think of it as sort of recycling capital. We transitioned a Bickford loan to a lease and.

We transitioned a LCS mortgage to a lease. Those aren't totally new dollars going out.

Omotayo Okusanya
Analyst, Mizuho

Right. They're offset. Okay.

John Spaid
EVP and CFO, National Health Investors

Yep.

Omotayo Okusanya
Analyst, Mizuho

Got you.

Eric Mendelsohn
President and CEO, National Health Investors

Makes sense.

Omotayo Okusanya
Analyst, Mizuho

All in all then, when you add up all those dollars, that's total investment of how much built into guidance?

John Spaid
EVP and CFO, National Health Investors

You're talking about new dollars going out, is that your question?

Omotayo Okusanya
Analyst, Mizuho

Yes.

John Spaid
EVP and CFO, National Health Investors

It's roughly in the $200 million range.

Omotayo Okusanya
Analyst, Mizuho

Okay. That's what I was wondering. Okay. That's helpful.

John Spaid
EVP and CFO, National Health Investors

Yeah. That's fulfilling, like you said, that's fulfilling our development and loan commitments. Not completely, right? We're not going to get them all filled this year. It's roughly 66% to 70% of those being fulfilled this year.

Omotayo Okusanya
Analyst, Mizuho

Okay.

John Spaid
EVP and CFO, National Health Investors

Of course, timing is a big part of that, right? Timing is a function of basically how much of the year are we going to get as those numbers get built into.

Omotayo Okusanya
Analyst, Mizuho

Yep

John Spaid
EVP and CFO, National Health Investors

Into our forecast.

Omotayo Okusanya
Analyst, Mizuho

Okay. That's helpful. Second of all, I just wanted to also kind of clarify around the transition portfolio itself. You kind of discussed built into guidance was this idea of you kind of get back to about 60% of the NOI from two years ago, from 2018. Could you just clarify again exactly how much NOI that's built into guidance then based on that assumption?

John Spaid
EVP and CFO, National Health Investors

I gave you a range, right? For two components, cash and GAAP. In 2018, we had $9.6 million in cash recognized and approximately $10.7 million in GAAP revenues. We're saying 40%-45% of cash and 60%-65% of GAAP. The reason for that is we've signed some longer term leases with Discovery and Senior Living Communities. The cash components of those really come about more in 2021 than they do in 2020.

Omotayo Okusanya
Analyst, Mizuho

Got you. Okay. That's helpful from that perspective. Okay. Just one more if you may, if I could indulge me. On your most recent disclosure about tenant purchase options, there was kind of a new purchase option there for an NHI-owned hospital that could be exercised as early as 2021. Just kind of curious, is this a new purchase option? It just kind of seems like it sprung in there this quarter and wasn't in prior disclosures.

Kevin Pascoe
Chief Investment Officer, National Health Investors

This is Kevin. It's not a new option. What it is we have an agreement with the operator there to extend the option into the first part of 2021. They're just not going to exercise their option this year. That's the change. Just to kind of add on to that, we feel like we have good relationships with each of these operators, and we're talking through scenarios in which we can do more things like that. Nothing's done yet, we feel like we have the ability to hopefully make some changes to be able to improve some of these options. In any event, we do feel like where the options do get exercised, it's capital that we'll get back, be able to redeploy. We'll be able to overcome in time.

We do recognize some of these, like the hospitals; those are high-yielding returns and so those are ones that we're definitely focused on and trying to do things like this where we can move them around, if at all possible.

Omotayo Okusanya
Analyst, Mizuho

Got you. Okay. That's helpful. Thank you.

Operator

Our next question comes from Connor Siversky with Berenberg. Please proceed.

Connor Siversky
Analyst, Berenberg

Hi, all, and thanks for having me on the call today. A quick follow-up to Tayo's first question, looking at some of these loan commitments and development commitments. Can you provide any color as to the timing, maybe, of some of the completion of these bigger projects?

John Spaid
EVP and CFO, National Health Investors

The bigger projects would be Sagewood, right? Obviously, that's controlled by the developer there, and we do expect that to open towards the end of this year. Most of the LCS Sagewood commitments will.

Not all, but most will be funded this year. You'll see some other items in there. They tend to be sort of front-end , a little bit heavy, and then they kind of maybe mitigate a little bit and then towards the back end be a little bit heavy, for the other sort of construction commitments. Ignite Medical Resorts is something we do expect to open here pretty soon. That's something that you should see get fully funded between now and the end of the second quarter. Does that help?

Connor Siversky
Analyst, Berenberg

Yep. Thanks for that. Maybe a little bit more of a high level question. Just looking at the external acquisition pipeline, given pretty strong performance of your portfolio could be considered secondary markets. Are you seeing any meaningful pricing pressures develop there, or are you being kind of pushed out of any deals you're looking at, or is the competitive environment relatively stable?

Kevin Pascoe
Chief Investment Officer, National Health Investors

This is Kevin. I feel like the environment is definitely still competitive. That said, those secondary markets have really been where we've built up a lot of good relationships and are able to find new deals where we can find either repeat business, which has kind of been our bread and butter, or find new growing operators, which we've also done a good job of over the last few years. As it stands, I feel like we're seeing the market pretty well. We're able to be competitive for some of those, and the key for us is to get there before it goes to a broker, really. If we can continue to make those inroads and kind of stay out of that competitive process, that's really where we're going to be successful.

Like I said, I feel like we have really good relationships there and can continue to make investments.

Connor Siversky
Analyst, Berenberg

Okay. How would that vary for the different asset classes? CCRCs versus ILFs or ALFs?

Kevin Pascoe
Chief Investment Officer, National Health Investors

Well, we just took down a lot on the CCRC side.

Connor Siversky
Analyst, Berenberg

Right.

Kevin Pascoe
Chief Investment Officer, National Health Investors

That's something we're going to monitor very closely from an exposure standpoint. I think if we continue to invest in the various asset classes that we have on a relative or proportional basis, that's a good place for us. The question came up earlier about doing some additional skilled nursing. That's always been on the table for us. We'd love to do it. At the same time, we've got to find the right operator and the right opportunity. We're open for business on really all asset classes. It's just really finding the right operator, right opportunity, and fit. I think that's really been what NHI has been as well, is opportunistic. We'll continue to look at senior housing, skilled nursing. We've said for a while we were looking at behavioral, that's still on the table.

It's just a matter of where we can make those relationships and continue to build them.

Connor Siversky
Analyst, Berenberg

All right. Cool. That's all from me. Thank you.

Operator

The next question comes line of Jordan Sadler with KeyBanc. Please proceed with your question.

Jordan Sadler
Analyst, KeyBanc Capital Markets

Thank you. Just clarifying somewhat on the pipeline, the LOIs, the $50 million you mentioned, John, is mix and pricing, what are we looking at there?

John Spaid
EVP and CFO, National Health Investors

Yeah, mix and pricing. I guess what I would say is, it's above our average. How does that help? Does that help?

Jordan Sadler
Analyst, KeyBanc Capital Markets

Better than average cap rates?

John Spaid
EVP and CFO, National Health Investors

Better than average lease rates, if you look at our commitments page. I'm sorry, our history on prior investments.

Jordan Sadler
Analyst, KeyBanc Capital Markets

Okay. Better than average lease rates. Is that a function of mix?

John Spaid
EVP and CFO, National Health Investors

Yeah, just mix and types and yeah. A variety of things. Yeah.

Jordan Sadler
Analyst, KeyBanc Capital Markets

Is it like SNFs or more development deals or what?

Kevin Pascoe
Chief Investment Officer, National Health Investors

Again, it varies. I would say it's still in the proportion that we just talked about, where it's majority senior housing. Some of it might be where it's secondary market or it might be where it's still leasing up. Things like that, where it deserves a little bit higher yield. Those are the kinds of things that we're looking at, but where they have good track records and continue to build or have already established a good rapport in those markets.

Jordan Sadler
Analyst, KeyBanc Capital Markets

Okay. While I've got you on guidance, come back to you, John, I guess. We talked about the purchase options, are you assuming the exercise of the one open purchase option this year in the guide?

John Spaid
EVP and CFO, National Health Investors

Yeah

Jordan Sadler
Analyst, KeyBanc Capital Markets

Actually, I don't mean the MOB, I mean the hospital that opens this year.

John Spaid
EVP and CFO, National Health Investors

Yes.

Jordan Sadler
Analyst, KeyBanc Capital Markets

You could speak to either or both. I assume the MOB, your expectation there is that it's not going to be purchased.

John Spaid
EVP and CFO, National Health Investors

Yeah. It's not that impactful either, so either way. Yes, the hospital is in there. In other words, we're expecting it to be exercised in our forecast.

Eric Mendelsohn
President and CEO, National Health Investors

Jordan, if I could make a plug for Kevin's ability to turn lemons into lemonade, remember that we had a huge purchase option with Legends in 2016, and that ended up being transformed into a new deal with Ensign. I've said before that the purchase options and lease maturities are things that we're hyper-focused on and spend a lot of time on here, working on. We'll give you more color as we get closer, but we view them as opportunities and conversation starters and not necessarily the end of a transaction or a relationship.

Jordan Sadler
Analyst, KeyBanc Capital Markets

Okay. That's helpful. How does that foot with John's comment that you're assuming it's being exercised?

Eric Mendelsohn
President and CEO, National Health Investors

Well, we have to be realistic and

John Spaid
EVP and CFO, National Health Investors

We like to underpromise and overdeliver.

Eric Mendelsohn
President and CEO, National Health Investors

we like to underpromise and overdeliver. We're assuming the worst. The moment we have a different update for you, we'll let you know.

Jordan Sadler
Analyst, KeyBanc Capital Markets

Okay.

John Spaid
EVP and CFO, National Health Investors

The opposite would be worse, right? I assume it doesn't go away, and then all of a sudden, it goes away.

Eric Mendelsohn
President and CEO, National Health Investors

For sure.

John Spaid
EVP and CFO, National Health Investors

a good outcome for us. Yeah.

Jordan Sadler
Analyst, KeyBanc Capital Markets

We wouldn't expect it of you guys. I can't remember because you had the two hospitals in there. Is this the one that had the fourth quarter opening?

Kevin Pascoe
Chief Investment Officer, National Health Investors

The one that was in the fourth quarter got pushed to the 1/1/2021.

Jordan Sadler
Analyst, KeyBanc Capital Markets

Okay.

Kevin Pascoe
Chief Investment Officer, National Health Investors

The one that's in March has been there for some time now.

Jordan Sadler
Analyst, KeyBanc Capital Markets

Okay.

Kevin Pascoe
Chief Investment Officer, National Health Investors

As I mentioned a moment ago, we have good relationships with them. There's an open dialogue. It's still their right, which is why we assume that it would get optioned.

Jordan Sadler
Analyst, KeyBanc Capital Markets

Okay. Just one other clarification on the Timber Ridge and Russ. Did you say only 20% is refundable?

John Spaid
EVP and CFO, National Health Investors

No.

Kevin Pascoe
Chief Investment Officer, National Health Investors

Non-refundable.

Jordan Sadler
Analyst, KeyBanc Capital Markets

80%?

Kevin Pascoe
Chief Investment Officer, National Health Investors

Yeah, 80% is refundable.

Jordan Sadler
Analyst, KeyBanc Capital Markets

80% refundable, okay.

Kevin Pascoe
Chief Investment Officer, National Health Investors

Yep.

John Spaid
EVP and CFO, National Health Investors

Yep.

Jordan Sadler
Analyst, KeyBanc Capital Markets

Got it. Thank you.

Kevin Pascoe
Chief Investment Officer, National Health Investors

Thank you.

John Spaid
EVP and CFO, National Health Investors

Thank you, Jordan.

Operator

Our next question comes from the line of Rich Anderson with SMBC. Please proceed to question.

Rich Anderson
Analyst, SMBC

Thanks. Good afternoon.

Kevin Pascoe
Chief Investment Officer, National Health Investors

Hey, Rich.

Rich Anderson
Analyst, SMBC

How you doing? I guess, can you just give an order of magnitude? Should we just put, like, a 10 cap on these purchase options for 2020 and 2021 and call it a day? Or you're not willing to sort of provide that level of coverage or color?

John Spaid
EVP and CFO, National Health Investors

Yeah, I would be cautious because we're still-

Kevin Pascoe
Chief Investment Officer, National Health Investors

They're negotiations.

John Spaid
EVP and CFO, National Health Investors

Yeah.

Rich Anderson
Analyst, SMBC

Okay.

John Spaid
EVP and CFO, National Health Investors

On prices and things like that.

Rich Anderson
Analyst, SMBC

Okay.

John Spaid
EVP and CFO, National Health Investors

Yeah.

Rich Anderson
Analyst, SMBC

I've lost my train of thought here. Oh, yeah. You've talked about all Kevin, you went through all your individual larger relationships. Bickford's still running at almost parity on a DARM basis in terms of coverage. I know there's some adjustments there with development and so on. On a DAR basis, which I would argue should be really the number you should lead with, but we can talk about that another time, it gets pretty close to one. I'm wondering if Bickford ever becomes a part of your line of thinking the way it did with Holiday, and you have to think about restructuring so you can get yourselves into a more comfortable coverage zone and not kind of put this matter to rest.

Kevin Pascoe
Chief Investment Officer, National Health Investors

I think we think of Bickford as a different scenario than Holiday. With Holiday, you have a financial owner. Bickford, this is a cultivated relationship over time, and frankly, they don't have billions sitting around. You can see that in their numbers. That said, I think we've talked about already, we've been very active with Bickford in terms of our discussions with them, how we optimize this relationship over time. I just think it's a very different approach. We've done some things around the edges, whether it's sell two buildings, continue with the development. We've worked with them on escalators. We've worked with them on some of smaller pieces on the rent. It's going to be something that plays out over time, and we can continue to make adjustments around the edges. Plus, all that factored into what we're seeing on the occupancy side.

They've put in the time. They've put in the effort. They're making strides on improving their business. As a whole company, you're right. They're running thinner than we'd like them to be. That fixed charge that they have as a company has improved each quarter over the course of the year. Something that we're keeping a very close eye on, but they're dedicated to this business, and I think they're doing all the right things. As Eric said in his comments, just about the kind of the NHI in total, but I think this would apply to Bickford as well, we're not out of the woods yet. We're doing a lot of work. They're working very hard. Feel like we're making progress, but it's going to be a different way to get there than, like, a Holiday scenario.

Rich Anderson
Analyst, SMBC

All right. I'm a believer in ripping the Band-Aid off, but I suppose every situation calls for different approaches. I want to get back also to the quasi-RIDEA structure with Timber Ridge. How would you describe the economics of this? In a conventional RIDEA, you own the real estate and the operations, and you pay a fee to a manager. Here, it's sort of gray areas, 80% of the real estate, 25% of the operations, for you guys. When you think of that sort of economically, are you kind of splitting it in half between RIDEA and triple net in this case? Is it like a 50/50 split, or is it something leaning more towards like a RIDEA structure or more towards like a triple net structure in the way the numbers are going to play out? If that question makes any sense at all.

Kevin Pascoe
Chief Investment Officer, National Health Investors

Yeah. Well, let me try to answer it, rein me back in if I'm not getting where you want to go. I think just from the PropCo side, clearly that is more like a triple net structure. They pay rent in-

Rich Anderson
Analyst, SMBC

Right

Kevin Pascoe
Chief Investment Officer, National Health Investors

They share in that rent. On the operating side, it was very important for our partner to have a real partner in the OpCo with them. That said, we are not operators. We feel like that's their business. We're happy to be their partner. We feel like they're a premier operator. In certain circumstances, and this is one of them, we're willing to take that risk, so to speak, or really have that opportunity with them. We're not the day-to-day owners, and I think that's really been our position to date on RIDEA anyway, is what we do is help with financial solutions and bring capital. We're not the day-to-day operators, and we don't feel like we should have that disproportionate risk.

In this case, we've set it up through a triple net lease, where the property will look a lot like what you've seen from us in the past. There's an opportunity on the OpCo side where they have the carrot to come to work every day and make a better return for themselves. We'll share in some of that, but it really was just aligning what each party does best and being willing to be a partner with them, but only to a certain level, because that's just not who we are.

Rich Anderson
Analyst, SMBC

Yep. Is 25% the maximum you can invest in an operator?

John Spaid
EVP and CFO, National Health Investors

This is John. No, it is not. I think that because of the nature of the refundable entrance fee liabilities, in this case, it kind of is. It is. Even though we don't know how we're going to book this for sure yet, but right now, we're not planning on fully consolidating the OpCo. Even though we don't reflect those liabilities on our balance sheet, it doesn't mean that we're not having to, in our compliance certificates with our bank lenders and private placement lenders, show them the effects of our pro rata share of ownership. We want to be a low-levered REIT, and that's sort of the situation in this case. In other cases, we could go higher. We did in Bickford, for example. Just a little different operator.

Rich Anderson
Analyst, SMBC

Okay. Well, I got it. Thanks very much.

John Spaid
EVP and CFO, National Health Investors

Thanks, Rich.

Operator

Our next question comes by with Daniel Bernstein with Capital One. Please proceed with the question.

Daniel Bernstein
Analyst, Capital One

Really everything I had on follow-up was answered. I'll just ask something real quick on the CCRCs, which is, there's some changes coming perhaps to the provider taxes. Is that altering how you underwrite CCRCs and did you underwrite that at all into the Timber Ridge purchase?

Kevin Pascoe
Chief Investment Officer, National Health Investors

This is Kevin. We're monitoring that. I don't think we have enough information today to say how it would impact. There frankly wasn't anything at the time to model into this. That said, the skilled components in particular in Timber Ridge is small compared to the rest of the building, we don't feel like it's going to be overly impactful. Where there are larger skilled units, it's definitely something that we'll be thinking about.

Daniel Bernstein
Analyst, Capital One

Okay. That's all I have. Thanks.

John Spaid
EVP and CFO, National Health Investors

Thanks, Daniel.

Operator

Our next question comes line of Omotayo Okusanya with Mizuho. Please proceed with the question.

Omotayo Okusanya
Analyst, Mizuho

Yes, just one quick follow-up. We talked quite a bit about uses of capital. I just wanted to focus on sources of capital a little bit going forward. What's the remaining balance on the ATM? Do you intend to kind of use that before it expires? Then this idea of kind of trimming out the line of credit, when do you think that could happen? Is that likely an unsecured debt offering?

John Spaid
EVP and CFO, National Health Investors

This is John again. I would say our leverage is in pretty good shape as it stands right now. The shelf expires in February. The current shelf, I would say, no, we really don't have a lot of capacity left. We had $95 million in capacity left. We did this convertible bond redemption in December, and the way we did it was in a way kind of a de-leveraging transaction because we took care of $60 million of debt on our balance sheet using a lot of our equity. We'll get the new shelf filed here, and you'll see a new number on there. At that point, kind of moving forward, we'll have more to say about that. I think I mentioned in my prepared remarks, when we think about our investments moving forward, we're thinking about them on a leverage-neutral basis.

We'll be back into the equity markets later this year as we make new investments. In terms of the term loan and trimming off the revolver, mid-year, we really do want to get something done here this year. We're going to have to free up some capacity for growth without using too much of our liquidity. We don't like to do that. We like to try to target about 50% of that revolver in free liquidity on average. That's kind of what we're thinking.

Omotayo Okusanya
Analyst, Mizuho

Great. Thank you.

Operator

Mr. Hambly, I will turn the call back over to you for any closing remarks.

Eric Mendelsohn
President and CEO, National Health Investors

All right. Thank you, everyone, and we'll look forward to seeing you at Nareit.